U.S. markets open in 9 hours 22 minutes

  • S&P Futures

    3,975.75
    -1.00 (-0.03%)
     

  • Dow Futures

    32,094.00
    +18.00 (+0.06%)
     

  • Nasdaq Futures

    11,914.25
    -28.00 (-0.23%)
     

  • Russell 2000 Futures

    1,800.00
    +3.20 (+0.18%)
     

  • Crude Oil

    110.87
    +0.54 (+0.49%)
     

  • Gold

    1,848.60
    +2.30 (+0.12%)
     

  • Silver

    21.86
    -0.01 (-0.02%)
     

  • EUR/USD

    1.0705
    +0.0021 (+0.19%)
     

  • 10-Yr Bond

    2.7490
    -0.0110 (-0.40%)
     

  • Vix

    28.37
    -1.08 (-3.67%)
     

  • GBP/USD

    1.2589
    +0.0010 (+0.08%)
     

  • USD/JPY

    127.3570
    +0.1160 (+0.09%)
     

  • BTC-USD

    29,799.28
    -319.39 (-1.06%)
     

  • CMC Crypto 200

    660.47
    -10.54 (-1.57%)
     

  • FTSE 100

    7,522.75
    +38.40 (+0.51%)
     

  • Nikkei 225

    26,706.84
    +29.04 (+0.11%)
     
WEF 2022:

Yahoo Finance is in Davos! Get the latest updates here

FDA Restricts Use Of Intercept's Ocaliva In Liver Disease with Advanced Cirrhosis Citing Risk Of Serious Liver Injury

  • Oops!
    Something went wrong.
    Please try again later.
Vandana Singh
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • ICPT
    Watchlist

  • The FDA has issued a statement restricting the use of Intercept Pharmaceuticals Inc’s (NASDAQ: ICPT) Ocaliva (obeticholic acid) in primary biliary cholangitis (PBC) patients with advanced cirrhosis.

  • PBC is a rare, chronic disease affecting the ducts in the liver that carry bile, which helps with digestion.

  • Some PBC patients with cirrhosis who took Ocaliva, especially those with evidence of advanced cirrhosis, developed liver failure, sometimes requiring liver transplants.

  • However, for patients who do not have advanced cirrhosis, “the benefits of Ocaliva outweigh the risks for PBC,” the FDA says in the statement citing clinical trials.

  • Also, B. Riley Securities analyst Mayank Mamtani downgraded the firm from Buy to Neutral and lowered the price target from $65 to $18.

  • The analyst no longer sees a favorable risk-reward given the view of “a narrowing path of market entry” in NASH. While “encouraged” by Intercept’s constructive dialogue with FDA, Mamtani sees a “high likelihood” of FDA denying approval based on surrogate approval unless a clear correlate is established prospectively with a clinical liver outcomes endpoint.

  • Though, the investors are apparently reacting to commentary from Jefferies saying that the FDA update to Intercept label for Obeticholic Acid was in line with expectations.

  • It sees the update to negatively impact 10-20% of the current PBC market.

  • Price Action: ICPT shares are up 8.7% at $16.81 during the market session on the last check Wednesday.

Latest Ratings for ICPT

May 2021

B. Riley Securities

Downgrades

Buy

Neutral

May 2021

B. Riley Securities

Downgrades

Buy

Neutral

May 2021

Goldman Sachs

Maintains

Neutral

View More Analyst Ratings for ICPT
View the Latest Analyst Ratings

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Recommended Stories

  • Why Shares of GameStop Are Surging Today

    Shares of the video game retailer GameStop (NYSE: GME) had popped nearly 26% as of 1:37 p.m. ET today as excitement over a potential short squeeze rose on social media. GameStop is the pioneer of the meme-stock movement that took 2021 by storm, so the stock is heavily susceptible to big random moves up and down. Today, it looks like interest in the stock on social media is building, as short interest has risen to the highest it's been in more than a year, according to analytics company Ortex.

  • Elon Musk committing another $6.25B to Twitter bid: SEC filing

    Yahoo Finance Live's Jared Blikre reports on Tesla CEO Elon Musk boosting his equity commitments towards his bid for Twitter, now totaling $33.5 billion.

  • Don’t get sucker-punched by capital gains taxes when you sell your home

    Longtime homeowners and those whose property value has skyrocketed could be in for a particularly nasty surprise. Here are some ways to reduce the tax bill.

  • Nvidia Stock Sank in After-Hours Trading Today -- Here's Why the Stock Could Be a Solid Buy

    The semiconductor titan is dealing with some near-term macroeconomic challenges, but its long-term future remains bright.

  • Nvidia stock falls after missing on second-quarter guidance

    Yahoo Finance's Jared Blikre examines Nvidia's Q1 earnings report and its stock movements in comparison to the rest of the semiconductor industry.

  • Dividend stocks have trounced the market this year. Here are 15 high-yield stocks expected to raise payouts the most through 2024

    DEEP DIVE The stock market, shocked by the Federal Reserve’s policy changes to fight inflation, has been gored this year, with growth and technology companies bearing the brunt of the biggest declines.

  • J.P. Morgan Makes 2 Bottom-Fishing Bets for Over 90% Upside Potential

    Stock markets have been bearing the brunt of multiple headwinds in recent months. Persistently high inflation, slowing GDP growth, and a jobs market that, while expanding in absolute terms, is still down from pre-pandemic levels are feeding fears that we’re facing a round of ‘70’s-style stagflation. And these have combined with geopolitical factors – the Russia-Ukraine war, the resumption of severe lockdown policies in China – to ratchet up worries about recession in the near term. It’s a tradin

  • Strong insider buying suggests a 15% rally in the S&P 500 from here

    One of the troubling things about this market downturn is that as brutal as it got, corporate insiders never showed much interest in their discounted stocks. Using history as a guide, the S&P 500 (SPX) the Dow Jones Industrial Average (DJIA) and the Nasdaq Composite (COMP) stand to advance 15%-20% over the next three months. “Quality” means buying by insiders with strong records, buying by executives over directors who are further from the business, and bullish formations like cluster buys.

  • Why Range Resources, Southwestern Energy, and NextDecade Stocks Jumped Double Digits on Wednesday

    Wednesday was yet another strong day for oil and gas stocks, but shares of natural gas companies stood out, with many soaring by double-digit percentages. Range Resources is a Texas-based natural gas exploration and production company with major operations in the Marcellus shale in Pennsylvania. The company also produces natural gas liquids and crude oil, but almost 70% of its production is natural gas.

  • Twitter Investors Deal a Big and Humiliating Blow to Musk

    Twitter did not provide any details about the proposed takeover offer from billionaire Elon Musk at its annual shareholder meeting.

  • Costco set to report Q3 earnings on Thursday afternoon

    Yahoo Finance Live's Seana Smith looks at Costco shares ahead of the retailer's earnings report coming out tomorrow.

  • Snowflake stock slides after earnings as company says macro issues are impacting some customer activity

    Shares of Snowflake Inc. tumbled in after-hours trading Wednesday after the software company delivered a forecast for the current quarter that came in below expectations at the midpoint.

  • Billionaire Steven Cohen Bets Big on These 2 High-Yield Dividend Stocks

    The markets these days are flashing warning signs for investors. High inflation and slowing GDP growth threaten a return to the stagflation of the late 70s, while China’s strict anti-COVID lockdowns and the Russia-Ukraine war are working together to keep supplies of oil, food, and manufactured goods short, supply chains tangled – and prices high. In short, it’s an investment environment that cries out for defensive plays. Dividend stocks are clear choice for investors looking to buy in. Their ap

  • Musk’s Revised Twitter Bid Drops Margin Loan, Requires More Cash

    (Bloomberg) -- Elon Musk is dropping plans to partially fund his purchase of Twitter Inc. with a margin loan tied to his Tesla Inc. stake and increasing the size of the deal’s equity component to $33.5 billion. Most Read from BloombergFed Saw Aggressive Hikes Providing Flexibility Later This YearBiden Demands US ‘Stand Up’ to Gun Makers After Texas AttackWhy So Few Big Rats Have Fled Putin’s ShipStocks Climb in Volatile Session After Fed Minutes: Markets WrapPlot to Kill George W. Bush in Reveng

  • 2 “Strong Buy” Stocks Under $10 That Are Too Cheap to Ignore

    The current market conditions – the NASDAQ is down 28% year-to-date, and the S&P 500 is down 17% – offer bargain hunters a target-rich environment. Plenty of sound stocks have seen their prices decline, pulled down by the general market headwinds and the overall stock trend, to levels that have left them too cheap to ignore. At this level, investors can find the benefits of cheap stocks, like those under $10, which offer both learning opportunities and huge upside potential. However, in evaluati

  • Analysts Say You Should Buy These 10 Stocks on the Dip

    In this article, we discuss the 10 stocks that analysts say you should buy on the dip. If you want to read about some more stocks that analysts say you should buy on the dip, click Analysts Say You Should Buy These 5 Stocks on the Dip. In a recent report, Bloomberg Economics claimed that […]

  • This is the photographic evidence presented in a lawsuit over fast-food burger sizes

    Are there legal consequences when restaurants advertise exaggerated versions of their menu items? The photographic evidence from one lawsuit.

  • Lost Among the Stock Splits: 1 Unstoppable Stock You'll Regret Not Buying on the Dip

    Stock splits might get investors excited, but here's a stock that's a big winner without one.

  • The Fed must boost rates by a full percentage point at every meeting to bring down inflation and avoid a job-killing recession

    The Fed is still not doing nearly enough to shrink the money supply and reduce excess demand for labor, energy, metals, houses, and other goods and services.

  • Why Zoom Stock Was Zooming on Wednesday

    What happened Battered by the recent tech stock rout, Zoom Video Communications (NASDAQ: ZM) was reversing course dramatically on Wednesday. Thanks largely to a high-profile investor's buy, the teleconferencing company's shares were up by nearly 10% in late afternoon trading.